期刊文献+

基于网络药理学探讨青钱柳调节血糖的作用机制 被引量:11

Mechanism of Cyclocarya Paliurus Regulating Blood Glucose Based on Network Pharmacology
下载PDF
导出
摘要 目的 通过网络药理学及分子对接的方法探讨青钱柳调节血糖的潜在作用机制。方法 通过文献对青钱柳进行化学成分搜集,利用Swiss ADME平台进行活性成分筛选,借助Swiss Target Prediction数据库进行作用靶点进预测,运用Cytoscape 3.8构建药物成分-靶点网络;检索Genecards,OMIM以及Disgenet数据库获取血糖靶点;通过韦恩图,得到青钱柳调节血糖靶点;使用String平台构建蛋白质-蛋白质相互作用(PPI)网络;使用metascape数据平台进行基因分类(GO)富集分析和京都基因和基因组百科全书(KEGG)通路分析。构建青钱柳调节血糖活性成分-共同靶点-信号通路网络。同时进行分子对接验证。建立实验性Ⅱ型糖尿病大鼠模型,检测大鼠空腹血糖(FBG)、空腹胰岛素(FIns)、糖化血红蛋白(HbA1c)水平,及大鼠胰脏组织ESR2、PTPN1的表达。结果 通过文献搜集筛选获得青钱柳39个活性成分,导入Swiss Target Prediction平台获得509个相关靶点。检索数据库获得血糖相关靶点1618个。二者取交集即为青钱柳调节血糖作用靶点134个,经PPI结果筛选得治疗靶点24个。GO富集分析共得主要条目中生物过程20条,细胞组成7条,分子功能10条。KEGG通路分析共得到核心信号通路8条。将8条通路涉及靶点与药物成分-靶点网络merge取交集后可得核心靶点18个,靶点连接的核心治疗成分29个。分子对接结果表明山奈酚、咖啡酸、槲皮素等核心成分与血糖调节相关蛋白及作用靶点具有较强的结合活性,可能具备相应的调节效果。青钱柳多糖能明显降低实验性Ⅱ型糖尿病大鼠模型FBG、FIns、HbA1c水平,提高大鼠胰脏组织ESR2、PTPN1的表达。结论 青钱柳可能是通过调节雌激素受体2型(ESR2)、酪氨酸蛋白磷激酶1型(PTPN1)、基质金属蛋白酶2型(MMP2)、金属蛋白酶2型(MMP9)、糖酶合酶激酶3B(GSK3B)、胰岛素样生长因子1受体(IGF1R)等靶点,在体内参与神经信号传导,发挥相关蛋白质合成,细胞间信号传递等功能来调节血糖。 Objective To explore the potential mechanism of Cyclocarya Paliurus in regulating blood glucose by network pharmacology and molecular docking. Methods The chemical constituents of Cyclocarya Paliurus were collected and active components were screened by Swiss ADME platform. The target prediction database of Swiss was used to predict the target, and Cytoscape 3.8 was used to construct the drug-target network;Genecards, OMIM and digenet databases were helping to find blood glucose targets;to obtain the blood glucose regulating targets of Cyclocarya Paliurus through Wayne map;The protein-protein interaction(PPI) network was constructed by using string platform;The gene ontology(GO) analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis were performed by using metascape data platform, which construct a common target signal pathway network of active components regulating blood glucose in Cyclocarya Paliurus. At the same time molecular docking verification was carried out. An experimental type 2 diabetic rat model was established. Fasting blood glucose(FBG), fasting insulin(FIns), glycosylated hemoglobin(HbA1 c) levels and expression of ESR2 and PTPN1 in pancreas tissue of rats were detected. Results Through literature collection and screening, 39 active ingredients of Cyclocarya Paliurus were obtained, and 509 related targets were obtained by importing them into the Swiss Target Prediction platform. The database was searched to obtain 1,618 blood glucose-related targets. The intersection of the two was the 134 targets of Cyclocarya Paliurus for regulating blood sugar, and 24 therapeutic targets are screened by the PPI results. In the GO enrichment analysis, there were 20 biological processes, 7 cell composition, and 10 molecular functions in the main items. A total of 8 core signal pathways were obtained from KEGG pathway analysis. The 8 pathways involving targets and the drug component-target network merge can get 18 core targets and 29 core therapeutic components connected to the targets. The results of molecular docking showed that core components such as kaempferol, caffeic acid, and quercetin had strong binding activity with blood glucose regulation-related proteins and targets, which may have corresponding regulatory effects. Polysaccharides from P. salicis significantly decreased the levels of FBG, FIns and HbA1 c in experimental type 2 diabetic rats, and increased the expression of ESR2 and PTPN1 in pancreas tissue of rats.Conclusion Cyclocarya Paliurus may regulate blood glucose by regulating Estrogen receptor beta(ESR2), Tyrosineprotein phosphatase non-receptor type 1(PTPN1), Matrix metalloproteinase-2(MMP2), Matrix metalloproteinase-9(MMP9), Glycogen synthase kinase-3 beta(GSK3 B), Insulin-like growth factor 1 receptor(IGF1 R) and other targets,which participate in nerve signal transduction in vivo, play related protein synthesis, intercellular signal transmission to regulate blood glucose.
作者 白玉晓 王添全 丁帅 夏西超 刘蔚 齐金旭 曹俊岭 欧阳竞锋 Bai Yuxiao;Wang Tianquan;Ding Shuai;Xia Xichao;Liu Wei;Qi Jinxu;Cao Junling;Ouyang Jingfeng(Kaifeng People's Hospital,Kaifeng 47500,China;School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 102488,China;Pingdingshan College,Pingdingshan 467000,China;Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China;Experimental Research Center,China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处 《世界科学技术-中医药现代化》 CSCD 北大核心 2021年第11期4017-4030,共14页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 河南省开封市科技发展计划项目(2106002):青钱柳多糖纠正Ⅱ型糖尿病糖代谢紊乱的实验研究,负责人:白玉晓 国家中医药管理局“全国中医药创新骨干人才”培养项目课题(国中医药人教函2019):课题名称,负责人:欧阳竞锋。
关键词 青钱柳 网络药理学 分子对接 高血糖 糖尿病 Cyclocarya Paliurus Network pharmacology Molecular docking Hyperglycemia Diabetes mellitus
  • 相关文献

参考文献23

二级参考文献306

共引文献6126

同被引文献239

引证文献11

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部